{"name":"Baudax Bio","slug":"baudax-bio","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":1269000,"revenueGrowth":17.5,"grossMargin":0,"rdSpend":3887000,"netIncome":-58795000,"cash":10032000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2022"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"N1539","genericName":"N1539","slug":"n1539","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"N1539","genericName":"N1539","slug":"n1539","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE0wVHRPbWl1UU1jUkxwNVltM2tXR1NLS216MkxQMDl2UDBCb3FnTzJ2YlltbmRvVFdoTmJkT21wTUhqVHlka0ZuRmUxUkpVRUQxaEstNy04dDFkRm5jdWNuQ2N1ZWRwS3p1Ynh0NnpyZU9SSTQ?oc=5","date":"2025-02-28","type":"pipeline","source":"VISTA.Today","summary":"Malvern-Based Baudax Bio Once Again Seeking to Extend Its Reorganization Plan Deadline - VISTA.Today","headline":"Malvern-Based Baudax Bio Once Again Seeking to Extend Its Reorganization Plan Deadline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPeTN5SEFmTXpURDlsTFRhSExGNGltaGwwOXQ2Qi1KY19pSWhxX3hrRWhPdVQ4cTlaQU9veUJkSEV0S0hiMTJrVThZNGU0ZlBLTU90TUwxZnZLaVA2aWVnN1ZpV0pSMDZzOGZ6WHBPcGNWcE1DakVyZ0F3NnlpRkVzcnRwbVE1R3BmY0t4Vk5OZ0wxVDBKZ2dwS210bGsxYXRGOUpFd2xxNkQ1T1g1TlE?oc=5","date":"2024-06-26","type":"deal","source":"The Business Journals","summary":"Baudax Bio asks bankruptcy court for more time to find deals for its drug patents - The Business Journals","headline":"Baudax Bio asks bankruptcy court for more time to find deals for its drug patents","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE1vUmdVMDhVaFhFU2I2T0dFZV9KTWlDODFNMDJnUTNNNEcyRlFhRUdjMzlMbUQ0LUI3c25DRjdjYzdieF84RjhHaWg4Wk9LSUZrNWg4MkZJV25Idw?oc=5","date":"2024-03-01","type":"pipeline","source":"TradingView","summary":"BXRXQ Stock Price and Chart — OTC:BXRXQ - TradingView","headline":"BXRXQ Stock Price and Chart — OTC:BXRXQ","sentiment":"neutral"},{"date":"2024-02-28","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPdzVLYVF0R0ZMcGZHOTFDSDFZQTh2R20yN1ZmZ1VjajBqZy1vck9MbTJoYXktTGVZR1J4TF9uX0FDUi1VdlhYaXc5S3psN1cteEJPRm1CaEZCaGtwMnNVWWh0UlYzSUxRX0g3OEpQZ2F1X05VMGFldTUyc3gtMXNMUjNBem5weHNGMDYyZ0ZBRXUzVFR4UUtLTmZxRWRlZ1cyTTY4aVVJZko3bFJzQ1E?oc=5","date":"2024-02-23","type":"pipeline","source":"The Business Journals","summary":"Baudax Bio files for bankruptcy a year after halting sales of its pain medicine Anjeso - The Business Journals","headline":"Baudax Bio files for bankruptcy a year after halting sales of its pain medicine Anjeso","sentiment":"neutral"},{"date":"2023-12-13","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2023-11-20","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2023-11-15","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2023-10-25","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2023-10-13","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2023-10-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2023-09-29","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5lZ0xWOHRlSHZoUHc1MXotMnQteGZ1ei15S1hJb3RXZk1LWnBXbEFSLUpQM0FzSElBVHVMRzVQV3gwQkRYMmw2MGJxdnJ5UE1Ebm1Nd2tzUDB0d3VJSHlKVURxYk53dlU?oc=5","date":"2023-07-06","type":"pipeline","source":"VISTA.Today","summary":"Malvern-Based Biotech Company Inherits Cell Therapy Treatments After New Aquisition - VISTA.Today","headline":"Malvern-Based Biotech Company Inherits Cell Therapy Treatments After New Aquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPTkpucWZjOUVyeGJkXzVkSFoxMmtXRUtockpBdl90RFR1dVJFRzlfMTVvMDJMTlM2ZDJ3M01MSVFxUWR1UHVTQXpUN1VIaEpCUi16SWdvT3JoRnpPekktZE5jQnBSeTdlalVXQzdoRUNnNV9ORkVTb3FYamNvTE5oaUt3OFdOWGN2U09LMDZPZE5VR0JYRWM3YUYzOFRuZmM5amV1RUdNbTE0TVpz?oc=5","date":"2023-02-27","type":"pipeline","source":"The Business Journals","summary":"Baudax Bio shelves pain medicine Anjeso, shifts focus to blocking agents - The Business Journals","headline":"Baudax Bio shelves pain medicine Anjeso, shifts focus to blocking agents","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNY0ZiNXlVM202SXE0cjRaUlZCaGRqNGlaaW9WclhKQ1RMRzRhcGt4S0VNZWxndjFIN2RCa0hYNUV2WUlqWWwyektycjVBT0lyOXN3azR3MHlLNXJ2TUI0LThENFpXRTVlTDQybjNwUnpnQTdDZ1VkRi1pS3Nob21jb0VBTHI5OFd5ZkJKMEk3NFFHQ0U2RFIxOEN1dHlVNkw1UFZJcmZ3dE1RZ3dVbENZ?oc=5","date":"2020-12-16","type":"pipeline","source":"The Business Journals","summary":"Malvern-based Recro Pharma names new CEO to replace founder Gerri Henwood - The Business Journals","headline":"Malvern-based Recro Pharma names new CEO to replace founder Gerri Henwood","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":1269000,"revenuePeriod":"2022-12-31","revenueHistory":[{"value":1269000,"period":"2022-12-31"},{"value":1080000,"period":"2021-12-31"},{"value":1080000,"period":"2021-12-31"},{"value":493000,"period":"2020-12-31"},{"value":493000,"period":"2020-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":3887000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-58795000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":10032000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}